Literature DB >> 34409498

Combination of ultrathin micro-patterned MXene and PEDOT: Poly(styrenesulfonate) enables organic electrochemical transistor for amperometric determination of survivin protein in children osteosarcoma.

Ping Xu1, Chunwen Lu2, Dahui Wang3, Dong Fu4.   

Abstract

An ultrathin micro-patterned MXene/PEDOT:PSS-based organic electrochemical transistor biosensor was constructed, which can significantly amplify the amperometric signal and transistor's performance. A novel interdigitated OECTs biosensor has been developed for reliable determination of survivin for the following considerations: (1) The synergistic effect of intercalated MXene and ionic PEDOT:PSS enhanced the mobility and volumetric capacitance of OECTs biosensor. (2) Compared with the best previous literatures, our assay demonstrated enhanced detection limit of survivin down to 10 pg mL-1, as well as satisfactory selectivity, reproducibility, and reliability. (3) Comparison of OECTs against commercial ELISA kit yielded favorable linearity (Y = 1.0015*X + 0.0039) and correlation coefficient (R2 = 0.9717). Those advantages are expected to pave the way to design of an OECTs biosensor with robustness, non-invasiveness, and miniaturization for the point-of-care applications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Interdigitated organic electrochemical transistor; Micro-patterned MXene and PEDOT: Poly(styrenesulfonate); Osteosarcoma; Survivin protein

Mesh:

Substances:

Year:  2021        PMID: 34409498     DOI: 10.1007/s00604-021-04947-2

Source DB:  PubMed          Journal:  Mikrochim Acta        ISSN: 0026-3672            Impact factor:   5.833


  22 in total

1.  Cell division and cell survival in the absence of survivin.

Authors:  Dun Yang; Alana Welm; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

2.  Modulation of Plasmon-Enhanced Resonance Energy Transfer to Gold Nanoparticles by Protein Survivin Channeled-Shell Gating.

Authors:  Magdalena Stobiecka; Agata Chalupa
Journal:  J Phys Chem B       Date:  2015-09-30       Impact factor: 2.991

3.  Piezometric biosensors for anti-apoptotic protein survivin based on buried positive-potential barrier and immobilized monoclonal antibodies.

Authors:  Magdalena Stobiecka; Agata Chalupa; Beata Dworakowska
Journal:  Biosens Bioelectron       Date:  2015-10-23       Impact factor: 10.618

4.  Expression and function of survivin in canine osteosarcoma.

Authors:  Jenette K Shoeneman; E J Ehrhart; Jens C Eickhoff; J B Charles; Barbara E Powers; Douglas H Thamm
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

5.  Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.

Authors:  Junquan Gu; Zhoujing Ji; Dong Li; Qirong Dong
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2019-01-01       Impact factor: 3.848

6.  Genome-Informed Targeted Therapy for Osteosarcoma.

Authors:  Leanne C Sayles; Marcus R Breese; Amanda L Koehne; Stanley G Leung; Alex G Lee; Heng-Yi Liu; Aviv Spillinger; Avanthi T Shah; Bogdan Tanasa; Krystal Straessler; Florette K Hazard; Sheri L Spunt; Neyssa Marina; Grace E Kim; Soo-Jin Cho; Raffi S Avedian; David G Mohler; Mi-Ok Kim; Steven G DuBois; Douglas S Hawkins; E Alejandro Sweet-Cordero
Journal:  Cancer Discov       Date:  2018-09-28       Impact factor: 39.397

Review 7.  Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.

Authors:  D Matthew Gianferante; Lisa Mirabello; Sharon A Savage
Journal:  Nat Rev Endocrinol       Date:  2017-03-24       Impact factor: 43.330

Review 8.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

9.  Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.

Authors:  S Khan; J R Aspe; M G Asumen; F Almaguel; O Odumosu; S Acevedo-Martinez; M De Leon; W H R Langridge; N R Wall
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

10.  Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.

Authors:  Xin Wang; Ge Qin; Xiaoting Liang; Wen Wang; Zhuo Wang; Dan Liao; Li Zhong; Ruhua Zhang; Yi-Xin Zeng; Yuanzhong Wu; Tiebang Kang
Journal:  Nat Commun       Date:  2020-02-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.